The total effect could exceed what any single mechanism would predict, which is consistent with the user reports of reduced cravings that seem disproportionate to the modest GLP-1 increase expected from probiotic supplementation
Altered intra-abdominal pressure : Changes in gastric volume and pressure may affect diaphragmatic function, as the diaphragm sits directly above the stomach
Sattar N, Lee MMY, Kristensen SL, et al
In mouse studies, NNMT inhibition reduced white adipose tissue mass by approximately 35% without any change in food intake
The report also cited adverse event reports involving symptoms such as severe gastrointestinal distress, vomiting, fainting, tachycardia, and injection-site complications
These are the outcomes of medically supervised GLP-1 and hormone therapy built around real lab work